相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2021)
Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers
Duygu Tosun et al.
BRAIN COMMUNICATIONS (2021)
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
Kathryn V. Papp et al.
ALZHEIMERS & DEMENTIA (2020)
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
David J. Irwin et al.
ANNALS OF NEUROLOGY (2020)
Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adults
Tengfei Guo et al.
NEUROLOGY (2020)
Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity
Brian B. Avants et al.
NEUROBIOLOGY OF AGING (2019)
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
Jorge J. Llibre-Guerra et al.
JAMA NETWORK OPEN (2019)
Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
Courtney L. Sutphen et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
The Relation Between Brain Amy o d Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease
Ling-Yun Fan et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain
Jun Wang et al.
NATURE REVIEWS NEUROLOGY (2017)
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
Shannon L. Risacher et al.
NEUROLOGY (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Longitudinal brain structural changes in preclinical Alzheimer's disease
Jordi Pegueroles et al.
ALZHEIMERS & DEMENTIA (2017)
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
Maartje I. Kester et al.
JAMA NEUROLOGY (2015)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models
Jorge L. Bernal-Rusiel et al.
NEUROIMAGE (2013)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Visinin-like Protein-1: Diagnostic and Prognostic Biomarker in Alzheimer Disease
Rawan Tarawneh et al.
ANNALS OF NEUROLOGY (2011)
Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly
J. Alex Becker et al.
ANNALS OF NEUROLOGY (2011)
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Melissa E. Murray et al.
LANCET NEUROLOGY (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Bradford C. Dickerson et al.
CEREBRAL CORTEX (2009)
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients
Jin-Moo Lee et al.
CLINICAL CHEMISTRY (2008)
分享论文
